Health Care Archives - Page 30 of 478

2 minute read

US Senate Grills UnitedHealth CEO Over Cyberattack Fallout, Ransom Payment

May 1, 3:52 PM

UnitedHealth Group's CEO addresses Senate concerns over cybersecurity risks, reassuring stability amid recent challenges. Learn more about the implications for healthcare and the economy.

UNH

2 minute read

Aging Pet Population Is ‘Solid Longer-Term Tailwind’ For IDEXX Labs: Analyst

By Vandana Singh

May 1, 3:27 PM

IDEXX Laboratories reports Q1 EPS of $2.81 (up 10% Y/Y), with sales reaching $964M (7% increase). Revenue growth driven by Companion Animal Group and Water segments. Operating margin at 31.0%. 2024 revenue forecasted at $3.895-$3.965 billion.

IDXX

2 minute read

Eli Lilly ‘On Its Way’ To $1 Trillion Market Cap, Analysts Say: It’s A ‘Have’ In A Sea Of ‘Have Nots’

By Vandana Singh

May 1, 3:26 PM

Eli Lilly's first-quarter report shows a revenue surge of 26%, beating EPS expectations. Analysts maintain a bullish outlook.

LLY

2 minute read

Johnson & Johnson Wants To Deal With Talc Lawsuit Overhang, Proposes $6.5B Settlement Package

By Vandana Singh

May 1, 2:42 PM

Johnson & Johnson announces $6.475 billion settlement for talc-related ovarian cancer lawsuits. Details on proposed resolution.

JNJ

1 minute read

Lung Disease-Focused United Therapeutics Says It Is A Compelling Investment Opportunity

By Vandana Singh

May 1, 2:35 PM

United Therapeutics impresses with record-breaking Q1 results. Revenue soars 34% Y/Y to $677.7 million, EPS jumps to $6.17. Tyvaso leads the charge with a 56% revenue surge.

UTHR

2 minute read

Investor Optimism Dampens as Walgreens Boots Alliance Struggles With Market Turbulence

By Vandana Singh

May 1, 1:42 PM

Walgreens Boots Alliance confronts challenges with a significant stock plunge, down 18% in April amidst revised outlook and tax liabilities. Strategic reviews aim to revive growth despite management shifts. Wall Street remains cautious amidst turbulent pharmaceutical market shifts.

WBA

2 minute read

TransMedics Stock Skyrockets, Analysts Call It ‘One Of The Best Organic Growth Stories’

By Vandana Singh

May 1, 1:13 PM

TransMedics shines with Q1 EPS at $0.35, and sales soared to $96.9 million. Fiscal 2024 revenue outlook raised to $390 million-$400 million. Analysts hail TransMedics' organic growth and strong market position, praising its innovative solutions and promising prospects.

TMDX

2 minute read

Setback For Novo Nordisk? Denmark Shifts Prescription Guidelines, Favoring Cost-Effective Alternatives For Ozempic

By Benzinga Neuro

May 1, 10:44 AM

The agency noted that in 2023, half of the new type 2 diabetes patients started their treatment with a reimbursed GLP-1 drug without trying a cheaper alternative first.

NVO

2 minute read

Pfizer Embraces Direct-To-Consumer Model For Covid Antiviral, Says Comirnaty Revenues Continue To Perform Consistently With Expectations

By Vandana Singh

May 1, 10:38 AM

Pfizer reports Q1 results: adjusted EPS beats estimates, driven by revenue growth. Significant declines in Comirnaty and Paxlovid revenues countered by operational gains. Company announces plans for direct-to-consumer online platform.

LLY

2 minute read

GSK Sees Strong Demand For Vaccines and Asthma Drugs, Raises Annual Outlook

By Vandana Singh

May 1, 9:42 AM

Discover GSK's first-quarter performance, boasting a 10% Y/Y sales surge to £7.4 billion. Notable growth in Vaccines and Specialty Medicines, propelled by strong demand for Arexvy and Shingrix. Expectations soar with raised 2024 EPS and sales forecasts.

BNTX